Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysisDonald E. Stull, L. Puig, C.E.M. Griffiths et al.|British Journal of Dermatology|2018Cited by 12
Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome AssessmentsDawn Odom, David McSorley, Lori McLeod et al.|Therapeutic Innovation & Regulatory Science|2017Cited by 1
Secukinumab treatment sustains patient-reported outcome benefits through 1 yearAlison J. Gottlieb, Peter Foley, Thomas G. Fox et al.|Unknown|2015Cited by 0